Johns Hopkins University

Gail J. McGovern was named President and CEO of the American Red Cross on April 8, 2008. Gail, who held top management positions at AT&T Corporation and Fidelity Investments, has experience running large organizations in competitive industries, and a track record for improving business performance and service delivery to the public. Gail joined the faculty of the Harvard Business School in June 2002 where she taught Marketing to first year students in the MBA program and Consumer Marketing to second year students. Prior to joining Harvard University, Gail was president of Fidelity Personal Investments, a unit of Fidelity Investments, serving 4 million customers with $500 billion in assets. In this role she had overall responsibility for Fidelity's retail mutual fund and brokerage businesses and was a member of Fidelity's Operating Committee. Gail joined Fidelity in September 1998 as president of Distribution and Services. Previously, she was Executive Vice President for the Consumer Markets Division at AT&T, responsible for AT&T's $26 billion residential long distance service and largest business unit. She began her career at AT&T as a computer programmer and moved up through sales, marketing and general management assignments, including chief strategist of AT&T's Communications Services Group and Executive Vice President of the $25 billion Business Markets Division. Born in 1952, Gail received a Bachelor of Arts degree in quantitative sciences from Johns Hopkins University in 1974. She received an MBA from Columbia University in 1987. Gail received alumna of the year from both universities. She is a member of the Board of Trustees of Johns Hopkins University, the Board of Directors of the Hartford Financial Services Group and the Board of Directors of DTE Energy. Gail was recognized by Fortune magazine in 2000 and 2001 as one of the top 50 most powerful women in corporate America.

Dr. Barbera is Executive Vice President, Chief Economist at ITG. He is responsible for ITG’s global economic and financial market forecasts. Dr. Barbera has spent the last twenty-two years as a Wall Street economist, earning a wide institutional following. Dr. Barbera was Chief Economist and Director of Economic Research at Lehman Brothers, and prior to that was Chief Economist at E.F. Hutton. Before arriving on Wall Street, Dr. Barbera served as a staff economist for U.S. Senator Paul Tsongas and as an economist for the Congressional Budget Office. Dr. Barbera also lectured at M.I.T. From mid-1994 through mid-1996, he was Co-Chairman of Capital Investment International, a New York based research boutique. Currently, he is an adjunct Professor of Economics at the Johns Hopkins University in Baltimore, Maryland. Dr. Barbera earned both his B.A. and Ph.D. from Johns Hopkins University.

Pamela P. Flaherty is President and Chief Executive Officer of the Citi Foundation. She is also Director of Corporate Citizenship for the company and a member of Citi's Management Committee. Previously, she managed Citibank's New York branch banking business and served as Citicorp's Senior Human Resources Officer. She began her career at the company in Citibank's International Banking Group. She is Chair of the Board of Trustees of Johns Hopkins University and also participates on the Boards of several non-profit organizations, including the Local Initiatives Support Corporation, Kenyon College, Colonial Williamsburg, and The Nature Conservancy Long Island Chapter. Pam is also a member of the Council on Foreign Relations. She is an honors graduate of Smith College and holds a Masters in International Affairs from Johns Hopkins Nitze School of Advanced International Studies.

Mr. Robert R. Grusky is the Founder and Managing Member of Hope Capital Management, LLC, an investment manager, since 2000. He co-founded New Mountain Capital, LLC, a private equity firm, in 2000 and was a Principal and Member from 2000 to 2005, and has been a Senior Advisor since then. From 1998 to 2000, Mr. Grusky served as President of RSL Investments Corporation. From 1985 to 1997, with the exception of 1990 to 1991 when he was on a leave of absence to serve as a White House Fellow and Assistant for Special Projects to the Secretary of Defense, Mr. Grusky served in a variety of capacities at Goldman, Sachs & Co., first in its Mergers & Acquisitions Department and then in its Principal Investment Area. He is also on the Board of Directors of AutoNation, Inc., and AutoZone, Inc., as well as a member of the Board of Trustees of Hackley School. Mr. Grusky has served on the Board since 2001, and is a member of the Audit Committee of the Board. He holds a bachelor s degree in history from Union College and an MBA from Harvard University. Mr. Robert L. Johnson is the Founder and Chairman of The RLJ Companies, which owns or holds interests in companies operating in the banking/financial services, real estate, hospitality, professional sports, film production, gaming and automotive industries. Mr. Johnson is the founder of Black Entertainment Television (BET), a subsidiary of Viacom and the leading African-American operated media and entertainment company in the United States, and served as its Chief Executive Officer until January 2006. In 2002, Mr. Johnson became the first African-American majority owner of a major sports franchise, the Charlotte Bobcats of the NBA. From 1976 to 1979, he served as Vice President of Governmental Relations for the National Cable & Telecommunications Association (NCTA). Mr. Johnson also served as Press Secretary for the Honorable Walter E. Fauntroy, Congressional Delegate from the District of Columbia. He also serves on the following boards: KB Home, Lowe s Companies, Inc., NBA Board of Governors, Deutsche Bank Advisory Committee, The Business Council, The Johns Hopkins University, and the Smithsonian Institution s National Museum of African American History and Culture. Mr. Johnson has served on the Board since 2003, and is a member of the Compensation Committee of the Board. He holds a bachelor s degree in social studies from the University of Illinois and a master s degree in international affairs from the Woodrow Wilson School of Public and International Affairs at Princeton University.

Ralph Terkowitz joined ABS Capital Partners in January 2004 as a General Partner and is responsible for investments in companies within the media & communication and technology sectors. Terkowitz represents ABS Capital on the boards of American Public Education, Inc., eFashionSolutions, LLC, Vibrant Media, Inc. and WhenU.com, Inc. He is also an observer on the board of Course Advisor, Inc. Previously serving as CIO/CTO of the Washington Post Company, Terkowitz brings more than 30 years of operating, financial and technical experience to ABS Capital. Terkowitz served as founder and CEO of its electronic publishing subsidiary, WashingtonPost.Newsweek Interactive (formerly DigitalInk). Also for the Washington Post, Terkowitz was also the CEO of Brass Ring for the Washington Post, one of the first business services providers. Brass Ring has grown to be one of the two largest outsourced recruiting platforms. Terkowitz serves on the board of TRUSTe and eCornell. In addition to his ABS Capital duties, he is a member of the board of advisors of the Wilmer Eye Institute at Johns Hopkins University, the Indian CEO High Tech Council, the Cornell University Council and the Newspaper Association of America's Business Committee on Industry Development.

Anna Mae Diehl, M.D. is a Professor of Medicine at Johns Hopkins University. Dr. Diehl serves on numerous Committees for the American Association for the Study of Liver Diseases, the American College of Physicians, the International Associate for the Study of Liver Diseases, the American Federation of Clinical Research, the American Society for Clinical Investigation, and the National Institute for Diabetes, Digestive and Kidney Diseases, as well as others. Dr. Diehl has served as a liver disease consultant for various pharmaceutical companies and serves on Editorial Boards for a number of journals including Hepatology, Practical Reviews in Gastroenterology, the American Journal of Physiology, and the American Journal of Medicine. Her research activities have focused on both clinical and pre-clinical studies of chronic liver diseases including alcohol and non-alcoholic liver steatohepatitis, liver regeneration and the role of cytokines in liver disease. Dr. Diehl has authored over 100 publications in the field of liver- and gastroenterology-related diseases.

Edward "Ned" Kelly was named Vice Chairman of Citi in July 2009 after serving as Citi's Chief Financial Officer since March 2009. He is responsible for driving the execution of Citi's strategic and operational priorities. Before that role, Ned was Head of Global Banking, Citi Private Bank and President and Chief Executive Officer of Citi Alternative Investments in Citi's Global Institutional Bank. He is a member of Citi's Senior Leadership and Executive Committees. Mr. Kelly joined Citi in February 2008 from The Carlyle Group, a private investment firm, where he was a Managing Director. Prior to joining Carlyle in July 2007, he was a Vice Chairman at The PNC Financial Services Group following PNC's acquisition of Mercantile Bankshares Corporation in March 2007. He was Chairman, Chief Executive and President of Mercantile from March 2003 through March 2007 and Chief Executive and President from March 2001 to March 2003. Before Mercantile, Mr. Kelly was at J.P. Morgan Chase & Co. where he was Managing Director and head of Global Financial Institutions and co-head of Investment Banking Client Management. He joined J.P. Morgan in 1994 as its General Counsel and Secretary. In 1996, he became a Managing Director and subsequently ran various parts of J.P. Morgan's investment banking business, including Global Financial Institutions and Latin America. Prior to joining J.P. Morgan, Mr. Kelly was a partner at the law firm of Davis Polk & Wardwell, where he specialized in matters related to financial institutions. Early in his career, Mr. Kelly served as a law clerk to Supreme Court Justice William J. Brennan, Jr. and U.S. Court of Appeals Judge Clement F. Haynsworth, Jr. Prior to law school, he served as a legislative assistant and, later, press secretary to U.S. Senator Richard S. Schweiker. He serves on the Boards of Directors of The Hartford Financial Services Group, CSX Corporation and SIFMA. He also serves on the Boards of Trustees of Johns Hopkins Medicine and the University of Virginia Law School Foundation. In the past, he has served on the Boards of Directors of CIT Group, Axis Capital Holdings, Paris Re Holdings, Constellation Energy, the American Stock Exchange, Johns Hopkins University and The Hershey Company, among others. Mr. Kelly received his bachelor's degree from Princeton University and his J.D. from the University of Virginia School of Law.

David Gordon has been a director since December 2006. He has been the Chief Executive Officer and a director of the Milwaukee Art Museum since October 2002. Before that, he was the Secretary (Director) of the Royal Academy of Arts in London for six years. He also spent 12 years as the Chief Executive Officer of The Economist Newspaper Ltd. He was associated with eFinancialNews for 10 years, first as a consultant and then as non-executive chairman and oversaw the sale of eFinancialCareers to us in 2006. Mr. Gordon also serves on the board of directors of Profile Books Ltd.

Dr. David Sidransky is the Director of the Head and Neck Cancer Research Division at Johns Hopkins University School of Medicine. In addition, he is Professor of Oncology, Otolaryngology-Head and Neck Surgery, Cellular & Molecular Medicine, Urology, Genetics, and Pathology at Johns Hopkins University and Hospital. Dr. Sidransky is certified in Internal Medicine and Medical Oncology by the American Board of Medicine. He has served as a Director of Imclone since January 2004. He is a founder of several private biotechnology companies and has served on the scientific advisory boards of many private and public companies including Medimmune, Telik, Roche and Amgen. He was formerly on the Board of Scientific Counselors at the NIDCR and is currently a member of the Recombinant DNA Advisory Committee at the National Institute of Health (NIH). Dr. Sidransky is a member of numerous editorial boards. He has over 250 peer-reviewed publications, has contributed more than 40 cancer reviews, and also has numerous issued biotechnology patents. He has been the recipient of many awards and honors, including the 1997 Sarstedt International Prize from the German Society of Clinical Chemistry, the 1998 Alton Ochsner Award Relating Smoking and Health by the American College of Chest Physicians, and the 2004 Hinda and Richard Rosenthal Award from the American Association of Cancer Research.

Don Kurz is currently Managing Member and CEO of Artemis Capital Partners, LLC, an innovative hedge fund organization he co-founded in 2006. Prior to forming Artemis, Mr. Kurz founded the management consulting firm, Insight Creative Solutions Inc. in 2005. From 1990-2005 Mr. Kurz was employed by EMAK Worldwide, Inc. Mr. Kurz was Chairman, President and CEO for most of the six years prior to his departure in 2005. Mr. Kurz rejoined the Board of Directors of EMAK in June 2009. Prior to EMAK, Mr. Kurz spent 10 years as a management consultant with Coopers and Lybrand (now PriceWaterhouse Coopers) and Cresap McCormick and Paget/Towers Perrin. Mr. Kurz is currently a member of the Board of Trustees of The Johns Hopkins University, where he sits on the Finance and Debt Committees. Mr. Kurz received an MBA from Columbia University Graduate School of Business and a B.A. from The Johns Hopkins University, where he was a key member of the NCAA Division 1 national championship lacrosse team.

George A. Scangos, Ph.D. , age 60, assumed the position of Chairman of our Board on December 31, 2005. He has served as a member of our Board of Directors since October 2003. Since 1996, Dr. Scangos has been President and Chief Executive Officer of Exelixis, Inc., a drug discovery and development company. From 1993 to 1996, he served as President of Biotechnology at Bayer Corporation, a pharmaceutical company. At Bayer, Dr. Scangos held several positions, including Senior Vice President of Research and Development for Bayer s pharmaceutical division and then President of Bayer Biotechnology. He serves on the Board of Visitors at the University of California, San Francisco School of Pharmacy, the Board of Overseers at the University of California, Davis Medical School, the Advisory Board for the Cornell University Life Sciences Initiative, and the Boards of Directors of the Global Alliance for TB Drug Development, the California Health Institute (CHI), the Biotechnology Industry Organization (BIO), Entelos, Inc., a life sciences company, and Exelixis. Dr. Scangos received a B.A. in biology from Cornell University, a Ph.D. from the University of Massachusetts and a Jane Coffin Postdoctoral Fellow in the laboratory of Dr. Frank Ruddle at Yale University.

Dr. Gabrielson has more than 25 years of experience as a physician and faculty member at Johns Hopkins University. Currently, Dr. Gabrielson is a Professor of Pathology and Oncology at Johns Hopkins University School of Medicine, and Professor of Environmental Health Sciences at the Johns Hopkins University Bloomberg School of Public Health. He is also an attending physician at the Johns Hopkins Hospital and Bayview Medical Center. Dr. Gabrielson received his Bachelor of Science in Biology and Chemistry from the University of Illinois and M.D. from Northwestern University Medical School.

John W. Snow is chairman, president and chief executive officer of the CSX Corporation. Before joining CSX, Mr. Snow was a visiting fellow at the American Enterprise Institute, visiting professor of economics at the University of Virginia, administrator for the National Highway Traffic Safety Administration, and deputy undersecretary for the U.S. Department of Transportation. He is on the board of trustees of Johns Hopkins University and the University of Virginia Darden School Foundation and is chairman of the Business Roundtable and a member of the National Commission on Economic Growth and Tax Reform and the Executive Committee of the Business Council.

Dr. Sponseller is the co-founder of the OI Clinic at Kennedy Krieger Institute, where he holds active staff tenure. He is also the Chief of Pediatric Orthopedics at Johns Hopkins Hospital, the Vice Chairman of Orthopedic Surgery at Johns Hopkins Hospital and a Professor in Orthopedic Surgery at Johns Hopkins University.

Benjamin Solomon Carson, Sr. had a childhood dream of becoming a physician. Growing up in a single parent home with dire poverty, poor grades, a horrible temper, and low self-esteem appeared to preclude the realization of that dream. But, today, he is the director of pediatric neurosurgery at The Johns Hopkins Medical Institutions, a position he has held since 1984 at age 33. He is a professor of neurosurgery, oncology, plastic surgery, and pediatrics. In 1987, Dr. Carson gained world-wide recognition as the principal surgeon in the 22-hour separation of the Binder Siamese twins from Germany. This was the first time occipital craniopagus twins had been separated with both surviving. The procedure employed hypothermic arrest (the deliberate lowering of body temperature) and circulatory arrest, as well as sophisti-cated surgical reconstructive techniques for success. In 1997, Dr. Carson was the primary surgeon in the team of South African and Zambian surgeons that separated type-2 vertical craniopagus twins (joined at the top of the head) in a 28-hour operation. It represents the first time such complexly joined twins have been separated with both remaining neurologically normal. He is noted for his use of cerebral hemispherectomy to control intractable seizures as well as for his work in craniofacial reconstructive surgery, achondroplasia (human dwarfism), and pediatric neuro-oncology (brain tumors). Dr. Carson is a recipient of numerous honors and awards including more than 20 honorary doctorate degrees. He is a member of the American Academy of Achievement, the Horatio Alger Society of Distinguished Americans, the Alpha Omega Alpha Honor Medical Society, and many other prestigious organizations. He sits on the board of directors of numerous organizations, including Kellogg Company, Costco Wholesale Corporation, the Yale Corporation which is the governing body of Yale University, and America's Promise. In addition to his academic responsibilities, he is a highly regarded and requested motivational speaker who has addressed varied audiences from high school graduations to the keynote address at the 1997 President's National Prayer Breakfast. He is president and co-founder of the Carson Scholars Fund which recognizes young people of all backgrounds for exceptional academic and humanitarian accomplishments. He hopes this program will positively change the perception of high academic achievers among their peers across our nation.

Thomas J. Graham, M.D. is Chief, Hand Surgery; Vice Chairman, Orthopaedics; and Director at The Curtis National Hand Center. Dr. Graham is also Vice-Chairman of Orthopaedic Surgery at Union Memorial Hospital, Clinical Associate Professor of both Orthopaedic and Plastic Surgery at Johns Hopkins University, and the Medical Director of the Washington Redskins. Dr. Graham's expertise includes surgery of the hand, wrist and elbow, with a concentration on difficult reconstructions.

Mr. Miller, 81, is the retired Chairman and Chief Executive Officer and current Director Emeritus of Avery Dennison Corporation, a manufacturer of self-adhesive materials, labels, and office products, where he held various executive positions since 1964. He is a member of the Board of Directors of the LA 84 Foundation, the Los Angeles Sports Council and the Southern California Committee for the Olympic Games. He is also a Trustee of Southern California Public Radio/KPCC and Trustee Emeritus of Johns Hopkins University and Occidental College. Mr. Miller has served as Chairman of the Board of the Company since 1998. Effective immediately prior to the annual meeting on May 5, 2009, Mr. Miller will be succeeded as Chairman by Mr. Pasquale.

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has elected Edward J. Ludwig Chairman of the Board, effective immediately following the Annual Meeting of Shareholders to be held on February 13, 2002. Mr. Ludwig will succeed Clateo Castellini, who will continue as a member of the Board. In addition to serving as Chairman, Mr. Ludwig, 50, also will continue as BD's President and Chief Executive Officer. He has been President since June 1999 and Chief Executive Officer since January 2000. Mr. Ludwig joined the Company in 1979 and has held a variety of business and corporate positions of increasing responsibility over his 22-year tenure with BD. Mr. Ludwig is a graduate of Holy Cross College and Columbia University Business School.

Dr. Guikema is a risk and decision analyst specializing in risk and reliability analysis for complex infrastructure systems subject to natural hazards and deliberate attacks, modeling the effects of interactions within teams on the performance of technical systems, and environmental life-cycle analysis for complex systems. His research has been funded by the National Science Foundation, the Department of Energy, state agencies, and private utility companies. Dr. Guikema is an assistant professor in the Department of Geography and Environmental Engineering at Johns Hopkins University and has taught courses on risk and decision analysis, uncertainty modeling, and project management.

Over the past three decades, Alan Siegel has become one of the best-known figures in the branding business. He has achieved the stature of both pillar of the establishment and provocative iconoclast, while building a leading brand consultancy, Siegel+Gale, devoted to positioning global companies for competitive success. View complete bio...

is the Founder and Chairman of RLJ Companies, which owns or holds interests in the banking/financial services, real estate, hospitality, professional sports, film production, gaming and automotive industries. Mr. Johnson is the founder of Black Entertainment Television (BET), a subsidiary of Viacom and the leading African-American operated media and entertainment company in the United States, and served as its Chief Executive Officer until January 2006. In 2002, Mr. Johnson became the first African-American majority owner of a major sports franchise, the Charlotte Bobcats of the NBA. From 1976 to 1979, he served as Vice President of Governmental Relations for the National Cable & Telecommunications Association (NCTA). Mr. Johnson also served as Press Secretary for the Honorable Walter E. Fauntroy, Congressional Delegate from the District of Columbia. He also serves on the following boards: KB Home, Lowe s Companies, Inc., NBA Board of Governors, Deutsche Bank Advisory Committee, The Business Council, The Johns Hopkins University, and the Smithsonian Institution s National Museum of African American History and Culture. Mr. Johnson has served on the Board since 2003, and is a member of the Compensation Committee of the Board. He holds a bachelor s degree in social studies from the University of Illinois and a master s degree in international affairs from the Woodrow Wilson School of Public and International Affairs at Princeton University.

Mr. McCarty is the Chief Network Officer for the Johns Hopkins University and the Johns Hopkins Health System. He is responsible for networking, telecommunications, network security, web infrastructure and the Local Area Networking environment. He has been involved in IT since the mid 1970's. His background and experiences include various senior management positions with responsibility for applications development, operations and technical support, systems integration, web based architectures, networking and telecommunications. He is currently involved with a number of major projects that include: widespread deployment of wireless technologies; implementation of high bandwidth computing services involving animation, image information and research in a virtual environment; Internet 2 activities including work with the National Science Foundation on the development and deployment of middle-ware products and services, as well as innovative efforts dealing with network security. Prior to joining Hopkins, Mr. McCarty was president of Adaptive Sciences Corporation. Adaptive Sciences was a consulting firm that provided senior level IT management services. Prior to his involvement with Adaptive Sciences, Mr. McCarty had been a Vice President with the USF&G Corporation for eleven years.

James McPartland, Ph.D. is executive director of the Center for Social Organization of Schools at Johns Hopkins University, the parent organization of Talent Development High Schools (TDHS).A He is the author of numerous research studies on the equality of educational opportunities and the process of whole school reform, and leads the Johns Hopkins team that developed the TDHS model.A He is frequently invited to work with government agencies and foundations on projects to improve American high schools with populations of students placed at risk for academic failure and dropping out. McPartland received his bachelora s and mastera s degrees from Cornell University and a doctorate in sociology from Johns Hopkins University.

Ron Fairchild is executive director of the National Center for Summer Learning at Johns Hopkins University. Under Mr. Fairchild?s leadership since 2002, the Center has grown from a local program serving the children of Baltimore city, to become the only national organization focused exclusively on creating opportunities for high-quality summer learning for all young people. In 2007, the Center?s efforts led to more than $14 million in public investment in summer programming for youth. Mr. Fairchild?s strategic direction continues to drive the Center?s efforts to close the achievement gap between disadvantaged youth and their higher-income peers. Mr. Fairchild is widely recognized as an authority on the issues of summer learning. He speaks regularly on research-based approaches and models of effective summer learning programs. His frequent appearances in the media include segments on NPR, CNN, NBC Nightly News, and the CBS Early Show. Fairchild has co-authored numerous publications including Making the Most of Sum

Andrew L. Singer is an assistant professor of surgery and surgical director of kidney transplantation at The Johns Hopkins University and Hospital. He received his medical degree with honor as well his Ph.D. in immunology from the University of Pennsylvania. Singer completed his general surgical training and a fellowship in multiorgan transplantation at The Johns Hopkins Hospital. He has participated in efforts to expand live-donor renal transplants, including paired kidney exchange and desensitization strategies. His basic science research focuses on molecular mechanisms of alloreactivity and novel strategies for immune modulation.

Dr. Rubin is Professor of Computer Science and Technical Director of the Information Security Institute at Johns Hopkins University. Rubin has been featured in the New York Times, the Washington Post, on CBS's 60 Minutes, ABC News, 20/20, and in many other media outlets for his pioneering work in computer security. Prior to forming ISE and joining Johns Hopkins, Rubin was a research scientist at AT&T Labs. Rubin has testified before Congress on several occasions, and he is author of dozens of refereed technical articles and several books including Brave New Ballot, Firewalls and Internet Security, Second Edition, White-Hat Security Arsenal, and Web Security Sourcebook. He is Associate Editor of IEEE Transactions on Software Engineering, Associate Editor of ACM Transactions on Internet Technology, Associate Editor of IEEE Security & Privacy, and an Advisory Board member of Springer's Information Security and Cryptography Book Series. In January, 2004 Baltimore Magazine named Rubin a Baltimorean of the Year for his work in safeguarding the integrity of our election process, and he is also the recipient of the 2004 Electronic Frontiers Foundation Pioneer Award. Rubin has a BS, MSE, and PhD from the University of Michigan.

Professor Denis Wirtz is co-Director of the Johns Hopkins Institute for NanoBioTechnology (INBT), Associate Director of a graduate training program in nanobiotechnology funded by the US National Science Foundation, Director of the graduate training program in nanotechnology for biology and Medicine funded by the Howard Hughes Medical Institute, and Director of the postdoctoral training program in nanotechnology for cancer medicine, all at Johns Hopkins University. After he gained his degree in physics engineering from the Free University of Brussels, Belgium, Professor Wirtz went on to gain his M.S. and Ph.D in chemical engineering from Stanford University under the supervision of Professor Gerald G. Fuller. After completing his postdoctoral fellowship at the Ecole Superieure de Physique et Chimie Industrielles in Paris, France, he returned to the United States to take a position as Assistant Professor in the Department of Chemical Engineering at John Hopkins University. Professor Wirtz is a member of the editorial board of the Biophysical Journal, Cell Adhesion and Migration, and Nanomedicine: Nanotechnology, Biology and Medicine. He is also a Fellow of the American Institute for Medical and Biological Engineering. In 2005, he became the co-Director and co-Founder of the John Hopkins University Institute for Nanobiotechnology, and is Director of the graduate training program in nanobiotechnology. Professor Wirtz has authored or co-authored over 90 peer-reviewed articles, with more than 2700 citations. He is regularly invited to give talks at international conferences and was the keynote speaker at the 13th Yonsei International Symposium in Seoul, Korea. He has also given numerous presentations at universities and research institutions around the world, including Stanford University, The Scripps Research Institute, Berkeley, MIT, Yale, the Ecole Federale Polytechnique de Lausanne in Switzerland, and Cambridge University in the UK.

Dr. Kathleen Kiernan, Director, is CEO of The Kiernan Group. She previously served as the assistant director for the Office of Strategic Intelligence and Information for the Bureau of Alcohol, Tobacco, Firearms and Explosives. While with the ATF, she was responsible for the design and implementation of an intelligence-led organizational strategy to mine and disseminate data related to explosives, firearms and illegal tobacco diversion. Dr. Kiernan has been involved with the intelligence community for over a decade. She served as the ATF representative to the Counterterrorism Center at the CIA from 1993 to 1995. She is a council vice president for the American Society for Industrial Security - a preeminent world-wide private sector organization comprised of subject matter experts in technology, security, law enforcement, the military, and academia. She is also former chair of the Law Enforcement Working Group, an initiative to bridge the intelligence and law enforcement communities. Dr. Kiernan is a senior member on the International Association of Chiefs of Police terrorism subcommittee, and an intelligence fellow and graduate of the FBI's National Executive Institute. She was recently named a senior fellow for the George Washington University Homeland Security Policy Institute.